EPA: Clinical Trials

11 trials of EPA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 active not recruiting. 11 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 10, Active not recruiting 1

Follow EPA: new trials by email Literature Review of EPA trials Research Report on EPA

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol
EPA + HT, EPA, Sunflower Oil - Hypertriglyceridemia, Normal
Not applicableActive not recruitingNational Research Council, Spain682025-02-172025-05-28
The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms
Eicosapentaenoic acid (omega-3 fatty acid), Specialized Pro-Resolving Lipid Mediator, Placebo - COVID - 19, Depression - Major Depressive Disorder
Not applicableCompletedNational Science and Technology Council, Taiwan542024-06-012026-07-21
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
EPA, DHA, sunflower oil - Metabolic Syndrome
Not applicableCompletedTufts University242016-03-012021-04-14
Impact of Smoking Information on Concerns About Radon
Radon & Smoking Synergistic, Radon Only, Radon and Smoking Isolated - Lung Neoplasms, Radon Exposure
Not applicableCompletedPaul Windschitl13902015-08-072019-04-19
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia
EPA, DHA, Placebo - Alzheimer Disease, Dementia Disorder
Not applicableCompletedTaichung Veterans General Hospital1632012-09-232021-07-26
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
EPA, DHA, Placebo - Cardiovascular Physiological Phenomena, Endothelial Nitric Oxide Synthase
Not applicableCompletedUniversity of East Anglia282012-09-012013-10-16
Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour
EPA, DHA, Placebo - Major Depressive Disorder
Not applicableCompletedNational Science and Technology Council, Taiwan2402012-08-012015-11-26
Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome
Niacin, Saturated meal, Monounsaturated meal - Metabolic Syndrome
Not applicableCompletedNational Research Council, Spain402012-01-012019-03-13
Time and Dose Evaluation of Stearidonic Acid (SDA) to Eicosapentaenoic Acid (EPA) in Red Blood Cells
Safflower Oil, EPA, SDA - Sudden Cardiac Death, Sudden Cardiac Arrest
Not applicableCompletedSolae, LLC1372009-08-012012-06-18
The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD
Eicosapentaenoic acid / Docosahexaenoic acid, Placebo dietary intervention (MUFA) in ADHD group, Placebo dietary intervention (MUFA) in healthy control group - Attention Deficit Hyperactivity Disorder, Healthy
Not applicableCompletedUnilever R&D792009-01-012013-12-11
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
Eicosapentaenoic Acid - Cancer Cachexia
Not applicableCompletedH. Lee Moffitt Cancer Center and Research Institute362007-07-012017-03-23

Conditions studied

Metabolic Syndrome (2)  ·  Alzheimer Disease (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Death, Sudden, Cardiac (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Hypertriglyceridemia (1)  ·  Lung Neoplasms (1)  ·  Risk Reduction Behavior (1)  ·  Smoking (1)

Sponsors

National Research Council, Spain (2)  ·  National Science and Technology Council, Taiwan (2)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Paul Windschitl (1)  ·  Solae, LLC (1)  ·  Taichung Veterans General Hospital (1)  ·  Tufts University (1)  ·  Unilever R&D (1)  ·  University of East Anglia (1)

Countries

Taiwan (3)  ·  Spain (2)  ·  United States (2)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Anne Marie Minihane, PhD (1)  ·  Kuan-Pin Su, MD PhD (1)  ·  Marco Hoeksma, PhD (1)  ·  Nagi Kumar, Ph.D. (1)  ·  Ratna Mukherjea, PhD (1)  ·  Sarah Durston, PhD (1)  ·  Stefania Lamon-Fava, PhD (1)  ·  Tsuo-Hung Lan, MD, PhD. (1)

Results publications

PMID 25790022, PMID 28648567, PMID 37058600